Stocks
ChemoCentryx (CCXI) EBITDA margin US GAAP (year values) |
|||||||||
| 2017 | 2018 | 2019 | 2020 | 2021 | LTM ? | CAGR 5 years ? | |||
| EBITDA margin, % | ? | 22.2% | -84.5% | -143.8% | -80.0% | -407.5% | -351.6% | ||
| Changes by years, y/y, % | +369pp | -107pp | -59pp | +64pp | -327pp | +3.3% | |||
ChemoCentryx. EBITDA margin, %
ChemoCentryx. EBITDA margin, changes, pp
ChemoCentryx (CCXI) EBITDA margin US GAAP (quarter values) |
||||||||
| 2021Q2 | 2021Q3 | 2021Q4 | 2022Q1 | 2022Q2 | LTM ? | |||
| EBITDA margin, % | ? | -2 208% | -116.6% | -1 695% | -677.7% | -255.4% | -351.6% | |
| Changes by years, y/y, % | -2 250pp | +359pp | -1 035pp | -395pp | +1 952pp | |||
| Changes by quarters, q/q, % | -1 925pp | +2 091pp | -1 578pp | +1 017pp | +422pp | |||
